Engineered Pan-Specific Reagents for N-Glycan Detection and Enrichment
Award amount
$2,018,187Program and phase
SBIR · Phase IIAward year
2024Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- LECTENZ BIO, INC.
- Proposal award date
- 2024-09-15
- Contract end date
- 2026-08-31
- UEI
- JTGCK219C6F4
- Solicitation number
- PA22-176
- Topic code
- 100
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Innovative glycan-specific reagents to accelerate the detection of disease biomarkers
- A new approach to monitoring glycosylation during glycoprotein production
- Engineered Pan-Specific Reagents for N-Glycan Detection and Enrichment
- Development of a suite of high-specificity fucose binding reagents
- Pan-specific tools and reagents for the enrichment of sialo-glycans
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- First-in-class TREM-1 inhibitors for neovascular retinal diseases
- Development of a Novel Biosensor to Accelerate Investigations of the Gut Microbiome
- Magnetic Lipid Nanoprobe Platform for Rapid, Highly-Efficient, and Cost-Effective Isolation of Extracellular Vesicles from Non-Invasive Bodily Fluids
- Scale-up and Manufacturing of STLR-201, an off-the-shelf regenerative therapeutic for Sjogren's syndrome-related dry eye disease
- Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturing
Research funding history
18 SBIR/STTR records share this UEI (2009–2025). Reported award amounts total $14,474,759. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services